Muscle stem cell study ends early — but may pave way for future treatments

NCT ID NCT06077734

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether muscle stem cells (mesoangioblasts) from people with muscle loss due to cancer or aging are healthy enough to be used for future cell therapy. Researchers took small muscle samples and blood from 7 participants and measured how well the cells grew and formed muscle. The study was stopped early, so results are limited, but it helps understand if a person's own stem cells could one day treat muscle wasting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATROPHY, MUSCLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cachexia Muscle Weakness muscular atrophy Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Maastricht Universitair Medisch Centrum

    Maastricht, Limburg, 6229HX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.